首页> 外文期刊>Journal of Neuro-Oncology >Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)
【24h】

Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)

机译:M.D. Anderson症状清单脑肿瘤模块(MDASI-BT)的验证

获取原文
获取原文并翻译 | 示例
           

摘要

Symptom occurrence has been shown to predict treatment course and survival in patients with solid tumors. Primary brain tumor (PBT) patients are unique in the occurrence of neurologic symptoms. Currently, no instrument exists that measures both neurologic and cancer-related symptoms.
机译:症状的发生已显示出可预测实体瘤患者的治疗过程和生存率。原发性脑肿瘤(PBT)患者在神经系统症状的发生中是独特的。当前,不存在可同时测量神经系统症状和癌症相关症状的仪器。

著录项

  • 来源
    《Journal of Neuro-Oncology》 |2006年第1期|27-35|共9页
  • 作者单位

    The University of Texas Health Science Center at Houston School of NursingThe University of Texas M.D. Anderson Cancer CenterNeuro-Oncology Unit 431 UT MDACC;

    The University of Texas M.D. Anderson Cancer Center;

    The University of Texas M.D. Anderson Cancer Center;

    The University of Texas M.D. Anderson Cancer Center;

    The University of Texas Health Science Center at Houston School of NursingThe University of Texas M.D. Anderson Cancer Center;

    The University of Texas Health Science Center at Houston School of NursingThe University of Texas M.D. Anderson Cancer Center;

    Pfizer Inc.;

    The University of Texas M.D. Anderson Cancer Center;

    The University of Texas M.D. Anderson Cancer Center;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    brain tumors; self-report instruments; symptoms;

    机译:脑肿瘤;自我报告工具;症状;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号